HomeSearchRegenerative Engineering and Translational Medicine

Regenerative Engineering and Translational Medicine

Springer International Publishing AG · Switzerland · Est. 2015

ISSN2364-4133eISSN2364-4141
SJR Q2WOS ESCIScopus / SJR
72
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
Scopus Q266
✓ Corroboration (1 more)+6
Total72
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
206
days submission → published
measured · last 19 articles · accept 174d
Q2
SJR Rank
Top 50% in field
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.533
H-Indexi
34
CiteScore
View ↗
Scopus metric · on the journal’s page
SNIPi
0.575
Total Worksi
578
Total Citationsi
4,974
2yr Mean Citednessi
1.88
Open Impact Factor alternative

Aims & Scope

Congratulations to Editor-in-Chief Professor Sir Cato T. Laurencin on receiving the 2026 Jensen Tissue Engineering Award, the highest honor of the Tissue Engineering and Regenerative Medicine International Society (TERMIS)! This award recognizes Dr. Laurencin’s contributions in the field of tissue engineering and regenerative medicine and affirms the distinctiveness of the vision, mission and purpose of the field of Regenerative Engineering. He will be receiving this distinction in November at the TERMIS-AM conference. Please join us in congratulating him. Regenerative Engineering and Translational Medicine is proud to welcome Dr. Edward A. Botchwey to the board as Assistant Managing Editor! Regenerative Engineering and Translational Medicine is the leading journal in the field covering convergence research in regeneration. The premier forum for research in advanced materials science, stem cells science, biophysics, developmental biology, and clinical translation for regeneration. A Journal for engineers, scientists, clinicians and lay people, with a lay abstract included for every paper. Highlights convergence research in pre-clinical, translational and clinical phases. A high profile Springer Nature journal and the official journal of the Regenerative Engineering Society.

General Information

Country / RegionSwitzerland
Primary LanguageEnglish
1st Year Published2015
Annual Volume~ 78 articles / year
StatusActive (last: 2026)
Total Publications578
Publisher OrgSpringer Science+Business Media
Visit Journal Website

Submission Info

Peer Review
Review Time
Acceptance Rate
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

6/12 · 50%
Do you know the journal / publisher?
Springer International Publishing AG
Does the journal have a website?
✓ Linked
Is the ISSN verified?
2364-4133 / 2364-4141
Indexed in a trusted database?
WoS, Scopus
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
57
1.1k
2019
52
651
2020
46
668
2021
50
447
2022
39
210
2023
44
308
2024
151
262
2025
85
13
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q2
BiomaterialsQ3
Biomedical EngineeringQ3
Cell BiologyQ4

Subject Classification

Web of Science Categories

Engineering, Biomedical

Scopus Categories

Biomedical EngineeringBiomaterialsMedicine (miscellaneous)Cell Biology

Research Topics (OpenAlex)

Electrospun Nanofibers in Biomedical ApplicationsBone Tissue Engineering MaterialsTissue Engineering and Regenerative Medicine3D Printing in Biomedical ResearchMesenchymal stem cell researchWound Healing and TreatmentsOsteoarthritis Treatment and MechanismsGraphene and Nanomaterials ApplicationsSilk-based biomaterials and applicationsPeriodontal Regeneration and Treatments

Frequently asked questions about Regenerative Engineering and Translational Medicine

Is Regenerative Engineering and Translational Medicine a predatory journal?

PubScope has no integrity flags on record for Regenerative Engineering and Translational Medicine: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 72/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Regenerative Engineering and Translational Medicine?

Regenerative Engineering and Translational Medicine is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.88.

Is Regenerative Engineering and Translational Medicine indexed in Scopus and Web of Science?

Regenerative Engineering and Translational Medicine is indexed in Web of Science, Scopus.

What is the aims and scope of Regenerative Engineering and Translational Medicine?

Congratulations to Editor-in-Chief Professor Sir Cato T. Laurencin on receiving the 2026 Jensen Tissue Engineering Award, the highest honor of the Tissue Engineering and Regenerative Medicine International Society (TERMIS)! This award recognizes Dr. Laurencin’s contributions in the field of tissue engineering and regenerative medicine and affirms the distinctiveness of the vision, mission and purpose of the field of Regenerative Engineering. He will be receiving this distinction in November at the TERMIS-AM conference. Please join us in congratulating him. Regenerative Engineering and Translat

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref